Iqstel shareholder consent clears issuance beyond 19.99% cap under USD 50 million M2B equity line

PUBT · 1d ago
Iqstel shareholder consent clears issuance beyond 19.99% cap under USD 50 million M2B equity line
  • Iqstel board actions, backed by majority shareholder written consent dated July 27, 2026, cleared key Nasdaq-related equity issuances and executive equity changes.
  • Authorized common stock issuance above the 19.99% Nasdaq cap under the $50 million M2B Funding equity line signed April 30, 2026.
  • Permitted common stock issuance above the 19.99% cap tied to Series D Preferred conversions under the ADI Funding arrangements, including true-up adjustments.
  • Adopted material employment-agreement amendments for CEO Leandro Iglesias and CFO Álvaro Quintana Cardona, including FY-2025 Series B Preferred awards of 20,000 and 14,000 shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Iqstel Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001663577-26-000234), on July 27, 2026, and is solely responsible for the information contained therein.